Biotechnology company Seattle Genetics has developed a reputation worldwide as a company that is creating breakthrough cancer therapies. Seattle Genetics has earned that reputation because of the tireless work of Dr. Clay Siegal and the caring, experienced staff at the facility. The company is known for developing and commercializing some of the most effective, innovative, antibody-based therapies used in the treatment of cancer today. The success of their antibody-drug conjugate technology has made them an industry leader in the fight against many forms of cancer.
Their ADC technology is one of the most effective cancer treatments seen in decades. It uses monoclonal antibodies to kill cancer cells and enhance antitumor activity without doing damage to the surrounding cells and tissue. This technology is currently licensed for use in 60 countries. Seattle Genetics also has a wide range of other cancer healing therapies in its deep product pipeline. Company president and CEO Dr. Clay Siegal has played a major role in the company’s success. Not only has he encouraged rigorous research and innovative drug development practices, Dr. Siegal has also raised millions in funding for the company.
An experienced scientist, Dr. Clay Siegal is very knowledgeable and talented and has a passion for his work. He has been involved with some of the leading companies involved in the fight against cancer. They include the National Institutes of Health,
Ultragenyx Pharmaceutical, Alder Biopharmaceuticals Inc. and Mirna Therapeutics, Inc. Dr. Clay Siegal has a B.S. in Zoology from University of Maryland and a Ph.D in Genetics from George Washington University and has been involved in cancer research and targeted cancer therapies for decades. His work is driven by a focus on helping patients.
Founded in 1998 and headquartered in Bothell, Washington, Seattle Genetics has partnered with companies worldwide to get their cancer fighting treatments into the hands and bodies of as many cancer patients as possible. Currently Seattle Genetics licenses their ADC technology to Genentech, Pfizer, AbbVie and GlaxoSmithKline to help patients worldwide. Dr. Clay Siegal has earned numerous awards for his work with Seattle Genetics. They include being voted Entrepreneur of the Year.